Autologous Platelet Gel in Wound Healing of Coronary Artery Bypass Grafting (CABG) Patients

University of Nebraska

Status: Withdrawn

Conditions: Infection; Wounds

Treatments: Biological: autologous platelet gel

Study type: Interventional

Funder types: Other

Identifiers

NCT00672672

0065-08-FB

Details and patient eligibility

About

This study will determine if autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease infection in coronary artery bypass grafting surgery patients.

Full description

The purpose of this study is to determine if the use of autologous platelet gel (APG) on sternal incision and conduit sites will improve wound healing and decrease the incidence of infection in patients undergoing coronary artery bypass grafting surgery

Sex: All

Ages: 19 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any patient who meets criteria and consents to undergo a CABG procedure involving conduit sites and consents to this study.

Exclusion criteria

• Any patient, after inclusion, whom is later determined to have had on-going therapy that could influence wound healing such as radiation or chemotherapy, extensive steroid use, or accidental trauma such as burns, etc.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups, including a placebo group

Platelet Gel

Experimental group

Description:

Participants receive platlet gel.

Treatment:

Biological: autologous platelet gel

Control (No platelet gel)

Placebo Comparator group

Description:

Participants do not receive platlet gel.

Treatment:

Biological: autologous platelet gel